Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
 Back to Profile

Todd Pitts

Concepts (400)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Colorectal Neoplasms
24
2024
793
2.830
 Why?
Xenograft Model Antitumor Assays
38
2024
870
1.960
 Why?
Protein Kinase Inhibitors
19
2020
916
1.820
 Why?
Triple Negative Breast Neoplasms
7
2024
202
1.410
 Why?
Antineoplastic Agents
25
2020
2135
1.410
 Why?
Azepines
5
2024
90
1.380
 Why?
Histone Deacetylase Inhibitors
5
2024
210
1.230
 Why?
Cell Line, Tumor
38
2025
3414
1.160
 Why?
Pyrimidines
9
2020
471
1.160
 Why?
Mice, Nude
25
2024
696
1.130
 Why?
Pancreatic Neoplasms
7
2025
936
1.010
 Why?
Carcinoma, Pancreatic Ductal
3
2025
287
1.000
 Why?
Pyrazines
6
2018
91
1.000
 Why?
Cell Proliferation
22
2024
2479
0.930
 Why?
Apoptosis
22
2024
2554
0.760
 Why?
Fluorouracil
1
2022
210
0.740
 Why?
Proto-Oncogene Proteins
6
2018
647
0.630
 Why?
Benzimidazoles
6
2024
168
0.620
 Why?
Camptothecin
5
2022
114
0.620
 Why?
Aurora Kinase A
4
2020
56
0.620
 Why?
Imidazoles
4
2018
239
0.610
 Why?
Drug Resistance, Neoplasm
12
2024
802
0.570
 Why?
Antineoplastic Combined Chemotherapy Protocols
10
2024
1688
0.550
 Why?
Drug Synergism
4
2014
383
0.540
 Why?
Mice
42
2025
17774
0.520
 Why?
Neoplasms
9
2022
2661
0.490
 Why?
Cell Cycle Proteins
2
2018
613
0.490
 Why?
Cell Cycle Checkpoints
3
2019
98
0.480
 Why?
Hydroxamic Acids
3
2011
89
0.480
 Why?
Wnt Signaling Pathway
5
2024
192
0.480
 Why?
Deoxycytidine
3
2024
178
0.470
 Why?
Receptor, IGF Type 1
3
2013
65
0.460
 Why?
Melanoma
5
2024
757
0.460
 Why?
Animals
47
2025
36862
0.450
 Why?
Disease Models, Animal
11
2025
4284
0.440
 Why?
Pyrazoles
5
2018
423
0.440
 Why?
Antimitotic Agents
1
2013
8
0.430
 Why?
Adrenocortical Carcinoma
3
2020
65
0.430
 Why?
Gene Expression Regulation, Neoplastic
10
2024
1399
0.430
 Why?
Mitogen-Activated Protein Kinases
3
2014
313
0.430
 Why?
Tumor Microenvironment
5
2022
674
0.430
 Why?
Tumor Suppressor Protein p53
5
2024
530
0.420
 Why?
Molecular Targeted Therapy
3
2024
413
0.420
 Why?
G2 Phase Cell Cycle Checkpoints
4
2022
44
0.410
 Why?
Signal Transduction
18
2024
5078
0.400
 Why?
Cyclin-Dependent Kinases
1
2013
132
0.390
 Why?
TOR Serine-Threonine Kinases
2
2018
412
0.390
 Why?
Boronic Acids
2
2011
38
0.390
 Why?
Quinoxalines
4
2020
66
0.370
 Why?
Dasatinib
2
2024
54
0.360
 Why?
Gene Expression Profiling
8
2024
1774
0.340
 Why?
Colonic Neoplasms
2
2013
256
0.340
 Why?
Drug Screening Assays, Antitumor
5
2020
195
0.340
 Why?
Humans
68
2025
137294
0.330
 Why?
Heterografts
3
2021
138
0.330
 Why?
Biomarkers, Tumor
6
2018
1274
0.330
 Why?
Programmed Cell Death 1 Receptor
3
2025
251
0.320
 Why?
Oxidoreductases Acting on CH-CH Group Donors
2
2020
26
0.310
 Why?
Phosphatidylinositol 3-Kinases
6
2018
365
0.300
 Why?
Adrenal Cortex Neoplasms
2
2020
63
0.290
 Why?
Ephrin-B2
2
2019
47
0.280
 Why?
Cell Cycle
7
2018
601
0.280
 Why?
Enzyme Inhibitors
5
2020
839
0.280
 Why?
Piperazines
2
2020
350
0.280
 Why?
Quinazolines
3
2015
250
0.270
 Why?
Drug Delivery Systems
1
2010
362
0.260
 Why?
Antibodies, Monoclonal, Humanized
2
2024
805
0.260
 Why?
Anilides
2
2018
73
0.250
 Why?
Mitogen-Activated Protein Kinase Kinases
3
2019
134
0.250
 Why?
Oncogene Proteins, Fusion
2
2018
215
0.250
 Why?
Female
41
2025
73052
0.250
 Why?
Protein-Lysine 6-Oxidase
1
2025
14
0.240
 Why?
Organoids
2
2024
112
0.240
 Why?
Gene Dosage
4
2015
144
0.240
 Why?
Mutation
9
2018
3956
0.230
 Why?
Nephritis, Interstitial
1
2025
14
0.230
 Why?
Immunoblotting
6
2015
307
0.230
 Why?
Cyclosporine
2
2018
268
0.230
 Why?
Gene Regulatory Networks
2
2024
309
0.230
 Why?
Collagen Type I
1
2025
133
0.230
 Why?
Pyrimidinones
2
2015
113
0.220
 Why?
Proto-Oncogene Proteins B-raf
3
2018
226
0.220
 Why?
Lymphocytes, Tumor-Infiltrating
3
2020
209
0.220
 Why?
RNA, Small Interfering
2
2024
622
0.220
 Why?
Bevacizumab
1
2024
136
0.210
 Why?
ras Proteins
4
2013
153
0.210
 Why?
Endogenous Retroviruses
1
2024
37
0.210
 Why?
Proto-Oncogene Proteins p21(ras)
6
2016
267
0.210
 Why?
Receptor, Notch1
2
2015
64
0.210
 Why?
Mucous Membrane
1
2024
125
0.210
 Why?
Pyridones
2
2015
168
0.210
 Why?
Neoplasm Transplantation
4
2018
257
0.210
 Why?
Collagen
1
2025
446
0.200
 Why?
Paclitaxel
1
2024
227
0.200
 Why?
Pyridines
2
2018
506
0.200
 Why?
Antineoplastic Agents, Immunological
3
2020
189
0.200
 Why?
Ataxia Telangiectasia Mutated Proteins
1
2022
66
0.200
 Why?
HCT116 Cells
3
2018
80
0.200
 Why?
Immunotherapy
3
2022
641
0.190
 Why?
Doxorubicin
1
2024
365
0.190
 Why?
Drug Design
2
2013
167
0.190
 Why?
beta Catenin
2
2020
253
0.180
 Why?
Gene Knockdown Techniques
4
2020
327
0.180
 Why?
Momordica charantia
1
2020
15
0.170
 Why?
Benzoxazoles
1
2020
19
0.170
 Why?
DNA-Binding Proteins
2
2020
1501
0.170
 Why?
HT29 Cells
2
2018
40
0.170
 Why?
Neoplasms, Experimental
2
2019
176
0.160
 Why?
Immune System
1
2021
177
0.160
 Why?
eIF-2 Kinase
1
2019
31
0.160
 Why?
src-Family Kinases
2
2017
92
0.160
 Why?
Inhibitory Concentration 50
2
2016
90
0.150
 Why?
Receptor, EphB4
1
2019
34
0.150
 Why?
DNA Helicases
1
2020
145
0.150
 Why?
Tumor Burden
2
2018
309
0.150
 Why?
Plant Extracts
1
2020
200
0.150
 Why?
Breast Neoplasms, Male
1
2018
29
0.150
 Why?
Coenzymes
1
2018
20
0.150
 Why?
4-Aminobenzoic Acid
1
2018
7
0.150
 Why?
Thermodynamics
1
2020
420
0.140
 Why?
MAP Kinase Kinase Kinases
2
2015
73
0.140
 Why?
Septins
1
2018
43
0.140
 Why?
Neoplasm Proteins
2
2020
434
0.140
 Why?
Adrenal Cortex
1
2018
29
0.140
 Why?
Oncogene Proteins v-abl
1
2017
5
0.140
 Why?
Neoplasm Invasiveness
3
2020
508
0.140
 Why?
Colorectal Neoplasms, Hereditary Nonpolyposis
1
2018
35
0.140
 Why?
Angiogenesis Inhibitors
3
2018
226
0.130
 Why?
Kidney
1
2025
1467
0.130
 Why?
Vascular Endothelial Growth Factor Receptor-2
2
2014
86
0.130
 Why?
Ubiquitin-Activating Enzymes
1
2016
17
0.130
 Why?
Cyclopentanes
1
2016
20
0.130
 Why?
Transplantation, Heterologous
4
2022
195
0.130
 Why?
Skin Neoplasms
1
2024
852
0.130
 Why?
Tumor Cells, Cultured
4
2020
954
0.130
 Why?
Corynebacterium
1
2017
49
0.130
 Why?
Corynebacterium Infections
1
2017
41
0.130
 Why?
Tankyrases
1
2016
15
0.130
 Why?
Insulin-Like Growth Factor I
1
2018
316
0.120
 Why?
Cetuximab
1
2016
95
0.120
 Why?
Capecitabine
1
2015
46
0.120
 Why?
Cyclin-Dependent Kinase Inhibitor p21
1
2016
121
0.120
 Why?
Amyloid Precursor Protein Secretases
2
2013
80
0.120
 Why?
Biliary Tract Neoplasms
1
2015
30
0.120
 Why?
Autophagy
1
2018
281
0.120
 Why?
Drug Discovery
1
2016
141
0.120
 Why?
Genes, ras
2
2018
97
0.120
 Why?
Cell Survival
3
2019
1119
0.120
 Why?
Adenocarcinoma
2
2020
939
0.120
 Why?
Diphenylamine
1
2014
9
0.120
 Why?
Gene Expression Regulation
1
2024
2608
0.110
 Why?
DNA Copy Number Variations
1
2015
182
0.110
 Why?
Germ-Line Mutation
2
2018
172
0.110
 Why?
Piperidines
1
2015
206
0.110
 Why?
Proto-Oncogene Proteins c-met
1
2014
75
0.110
 Why?
Middle Aged
14
2024
33310
0.110
 Why?
Benzamides
1
2014
217
0.110
 Why?
Protein Kinases
1
2015
319
0.110
 Why?
Up-Regulation
1
2016
844
0.100
 Why?
Urinary Bladder Neoplasms
1
2016
251
0.100
 Why?
Tetrahydronaphthalenes
1
2013
29
0.100
 Why?
Receptor, Insulin
1
2013
105
0.100
 Why?
Valine
1
2013
82
0.100
 Why?
Aged
11
2024
23851
0.100
 Why?
Neutrophils
4
2019
1236
0.100
 Why?
Bortezomib
2
2011
55
0.100
 Why?
Receptors, Notch
1
2013
88
0.100
 Why?
Tumor Suppressor Proteins
1
2015
327
0.100
 Why?
Mitosis
1
2013
193
0.100
 Why?
Antineoplastic Agents, Phytogenic
1
2013
190
0.090
 Why?
3' Untranslated Regions
1
2012
145
0.090
 Why?
Aldehyde Dehydrogenase
1
2012
100
0.090
 Why?
Sirolimus
1
2013
275
0.090
 Why?
Proteasome Inhibitors
1
2011
46
0.090
 Why?
Carcinoma, Squamous Cell
1
2016
684
0.090
 Why?
Head and Neck Neoplasms
1
2016
605
0.090
 Why?
Computational Biology
1
2015
646
0.090
 Why?
Benzodioxoles
1
2012
115
0.090
 Why?
Protease Inhibitors
1
2011
106
0.080
 Why?
Carcinogenesis
2
2024
217
0.080
 Why?
Proto-Oncogene Proteins c-akt
4
2018
436
0.080
 Why?
Mice, Inbred NOD
2
2022
601
0.080
 Why?
Phosphorylation
4
2019
1759
0.080
 Why?
Neoplasm Metastasis
3
2018
658
0.080
 Why?
Nuclear Proteins
1
2015
712
0.080
 Why?
Vascular Endothelial Growth Factor Receptor-3
1
2009
7
0.080
 Why?
Adult
12
2024
37724
0.080
 Why?
Mice, Inbred BALB C
3
2020
1269
0.080
 Why?
Vascular Endothelial Growth Factor Receptor-1
1
2009
72
0.080
 Why?
Breast Neoplasms
2
2012
2243
0.080
 Why?
Class I Phosphatidylinositol 3-Kinases
3
2014
95
0.070
 Why?
Gastrointestinal Neoplasms
1
2009
77
0.070
 Why?
Cell Movement
2
2011
969
0.070
 Why?
Male
15
2024
67560
0.070
 Why?
Positron-Emission Tomography
3
2018
295
0.070
 Why?
Immunosuppressive Agents
1
2013
890
0.070
 Why?
Carcinoma, Hepatocellular
1
2011
361
0.070
 Why?
Farnesyltranstransferase
1
2007
35
0.070
 Why?
Prognosis
4
2019
4026
0.070
 Why?
Oligonucleotide Array Sequence Analysis
3
2015
767
0.060
 Why?
Feasibility Studies
1
2010
949
0.060
 Why?
Protein Conformation
2
2020
940
0.060
 Why?
Microsatellite Repeats
2
2024
168
0.060
 Why?
Gene Expression
2
2019
1501
0.060
 Why?
Algorithms
3
2024
1692
0.060
 Why?
Transcription, Genetic
2
2024
1456
0.060
 Why?
Maximum Tolerated Dose
2
2020
198
0.060
 Why?
Reproducibility of Results
2
2010
3283
0.060
 Why?
Quinolones
1
2007
137
0.060
 Why?
Ipilimumab
1
2025
33
0.060
 Why?
Neovascularization, Pathologic
2
2018
301
0.060
 Why?
Disease Progression
2
2025
2752
0.060
 Why?
CTLA-4 Antigen
1
2025
99
0.060
 Why?
Models, Molecular
2
2020
1594
0.050
 Why?
Structure-Activity Relationship
2
2018
574
0.050
 Why?
Myeloid Cell Leukemia Sequence 1 Protein
2
2019
41
0.050
 Why?
Triazoles
1
2024
147
0.050
 Why?
Enhancer Elements, Genetic
1
2024
190
0.050
 Why?
HMGB1 Protein
1
2003
50
0.050
 Why?
Adrenergic alpha-Agonists
1
2002
28
0.050
 Why?
Proto-Oncogene Proteins c-raf
1
2002
45
0.050
 Why?
Adrenergic alpha-Antagonists
1
2002
34
0.050
 Why?
Neuroimmunomodulation
1
2002
65
0.050
 Why?
Magnetic Resonance Spectroscopy
2
2018
616
0.050
 Why?
Histone Deacetylase 1
1
2022
25
0.050
 Why?
Isoenzymes
1
2003
304
0.050
 Why?
Aurora Kinases
2
2012
27
0.050
 Why?
Histones
2
2022
636
0.050
 Why?
Adrenergic beta-Agonists
1
2002
133
0.050
 Why?
Treatment Outcome
4
2024
10800
0.050
 Why?
Endotoxemia
1
2002
86
0.050
 Why?
Caspase 3
2
2013
246
0.050
 Why?
Genetic Predisposition to Disease
1
2010
2419
0.040
 Why?
Chimerism
1
2021
31
0.040
 Why?
Acetylation
1
2022
248
0.040
 Why?
Extracellular Matrix
1
2025
527
0.040
 Why?
Flow Cytometry
2
2019
1184
0.040
 Why?
Campylobacter jejuni
1
2000
12
0.040
 Why?
Lymphocyte Subsets
1
2021
87
0.040
 Why?
Lymphoid Tissue
1
2021
75
0.040
 Why?
Cluster Analysis
2
2012
497
0.040
 Why?
Catalase
1
2000
131
0.040
 Why?
TCF Transcription Factors
1
2020
17
0.040
 Why?
Adrenergic beta-Antagonists
1
2002
323
0.040
 Why?
Histone Deacetylases
1
2022
215
0.040
 Why?
RNA, Neoplasm
1
2020
82
0.040
 Why?
Mice, SCID
1
2021
367
0.040
 Why?
Antimetabolites, Antineoplastic
1
2020
94
0.040
 Why?
Mechanistic Target of Rapamycin Complex 2
1
2020
62
0.040
 Why?
Indolizines
1
2019
4
0.040
 Why?
Forkhead Box Protein M1
1
2019
7
0.040
 Why?
Mechanistic Target of Rapamycin Complex 1
1
2020
125
0.040
 Why?
Small Molecule Libraries
1
2020
95
0.040
 Why?
MAP Kinase Kinase 2
2
2013
28
0.040
 Why?
Genomics
1
2024
792
0.040
 Why?
MAP Kinase Kinase 1
2
2013
75
0.040
 Why?
Crystallography, X-Ray
1
2020
485
0.040
 Why?
M Phase Cell Cycle Checkpoints
1
2018
24
0.040
 Why?
Genetic Linkage
1
1999
298
0.040
 Why?
High-Throughput Screening Assays
1
2020
160
0.040
 Why?
Flavin-Adenine Dinucleotide
1
2018
16
0.040
 Why?
NADP
1
2018
50
0.040
 Why?
Epithelial-Mesenchymal Transition
1
2020
209
0.040
 Why?
Radiotherapy
1
2019
202
0.040
 Why?
Nausea
1
2018
112
0.040
 Why?
Aldosterone
1
2018
45
0.040
 Why?
Multifactorial Inheritance
1
1999
174
0.040
 Why?
Kaplan-Meier Estimate
1
2020
892
0.040
 Why?
Hemorrhage
1
2002
723
0.030
 Why?
Area Under Curve
1
2018
315
0.030
 Why?
Drug Therapy, Combination
1
2020
1063
0.030
 Why?
Breast
1
2018
150
0.030
 Why?
DNA Damage
1
2020
422
0.030
 Why?
Diarrhea
1
2018
183
0.030
 Why?
Catalytic Domain
1
2018
226
0.030
 Why?
RNA
1
2024
924
0.030
 Why?
Recombinant Proteins
1
2020
1354
0.030
 Why?
Autistic Disorder
1
1999
204
0.030
 Why?
Disease-Free Survival
1
2018
687
0.030
 Why?
Axin Protein
1
2016
19
0.030
 Why?
Ubiquitination
1
2016
102
0.030
 Why?
Fatigue
1
2018
328
0.030
 Why?
T-Lymphocytes, Regulatory
1
2019
387
0.030
 Why?
Protein Isoforms
1
2017
403
0.030
 Why?
RNA, Messenger
2
2020
2839
0.030
 Why?
Administration, Oral
1
2018
812
0.030
 Why?
Sequence Analysis, RNA
1
2018
452
0.030
 Why?
Hypertension
2
2018
1285
0.030
 Why?
Serrate-Jagged Proteins
1
2015
27
0.030
 Why?
Jagged-1 Protein
1
2015
23
0.030
 Why?
Tumor Protein p73
1
2015
14
0.030
 Why?
Hematopoietic Stem Cell Transplantation
1
2021
615
0.030
 Why?
Gene Duplication
1
2015
68
0.030
 Why?
Binding Sites
1
2018
1309
0.030
 Why?
Biopsy
1
2018
1127
0.030
 Why?
NF-kappa B
3
2003
691
0.030
 Why?
Immunohistochemistry
1
2019
1734
0.030
 Why?
Databases, Genetic
1
2015
237
0.030
 Why?
Calcium-Binding Proteins
1
2015
218
0.030
 Why?
Mice, Knockout
1
2021
3009
0.030
 Why?
Caspase 7
1
2013
22
0.030
 Why?
Butadienes
1
2013
36
0.030
 Why?
Intercellular Signaling Peptides and Proteins
1
2015
382
0.030
 Why?
Cell Growth Processes
1
2013
52
0.030
 Why?
Survival Analysis
1
2016
1321
0.030
 Why?
Tumor Stem Cell Assay
1
2012
34
0.030
 Why?
Everolimus
1
2013
91
0.020
 Why?
Nitriles
1
2013
172
0.020
 Why?
Random Allocation
1
2013
353
0.020
 Why?
CD8-Positive T-Lymphocytes
1
2019
916
0.020
 Why?
Phenotype
1
2021
3202
0.020
 Why?
Immunoprecipitation
1
2012
155
0.020
 Why?
Cyclic AMP Response Element-Binding Protein
2
2003
145
0.020
 Why?
Neoplasm Staging
1
2015
1374
0.020
 Why?
p38 Mitogen-Activated Protein Kinases
2
2003
283
0.020
 Why?
Calcium Signaling
1
2013
249
0.020
 Why?
Kinetics
1
2014
1674
0.020
 Why?
Enzyme Activation
2
2003
813
0.020
 Why?
In Situ Hybridization, Fluorescence
1
2012
317
0.020
 Why?
PTEN Phosphohydrolase
1
2012
162
0.020
 Why?
Cellular Senescence
1
2012
187
0.020
 Why?
Li-Fraumeni Syndrome
1
2010
14
0.020
 Why?
Receptor, ErbB-2
1
2012
342
0.020
 Why?
Molecular Epidemiology
1
2010
67
0.020
 Why?
Proteasome Endopeptidase Complex
1
2011
155
0.020
 Why?
Population Groups
1
2010
62
0.020
 Why?
Neutropenia
1
2010
146
0.020
 Why?
Ki-67 Antigen
1
2010
111
0.020
 Why?
Capillary Permeability
1
2010
145
0.020
 Why?
Metabolome
1
2013
350
0.020
 Why?
Ligands
1
2011
664
0.020
 Why?
Drug Combinations
1
2010
344
0.020
 Why?
Nuclear Magnetic Resonance, Biomolecular
1
2011
340
0.020
 Why?
Keratinocytes
1
2010
248
0.020
 Why?
Transcriptome
1
2015
972
0.020
 Why?
Australia
1
2010
314
0.020
 Why?
Membrane Proteins
1
2015
1163
0.020
 Why?
Antibodies, Monoclonal
1
2015
1431
0.020
 Why?
Biomarkers
1
2019
4164
0.020
 Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2009
976
0.020
 Why?
Leukemia-Lymphoma, Adult T-Cell
1
2007
14
0.020
 Why?
Sulfonamides
1
2011
512
0.020
 Why?
Verapamil
1
2007
41
0.020
 Why?
Enzyme-Linked Immunosorbent Assay
1
2009
851
0.020
 Why?
Calcium
1
2013
1198
0.020
 Why?
Blotting, Western
1
2009
1226
0.020
 Why?
Clone Cells
1
2007
266
0.020
 Why?
Dose-Response Relationship, Drug
1
2010
2052
0.020
 Why?
Magnetic Resonance Imaging
1
2018
3568
0.020
 Why?
Calcium Channel Blockers
1
2007
167
0.020
 Why?
Family
1
2010
666
0.020
 Why?
Metabolomics
1
2011
679
0.010
 Why?
MicroRNAs
1
2012
699
0.010
 Why?
Cohort Studies
1
2015
5726
0.010
 Why?
Liver Neoplasms
1
2011
785
0.010
 Why?
Ovarian Neoplasms
1
2010
565
0.010
 Why?
Phosphotransferases
1
2003
24
0.010
 Why?
Class Ib Phosphatidylinositol 3-Kinase
1
2003
4
0.010
 Why?
bcl-Associated Death Protein
1
2003
9
0.010
 Why?
Phentolamine
1
2002
15
0.010
 Why?
Ribosomal Protein S6 Kinases
1
2002
21
0.010
 Why?
Brimonidine Tartrate
1
2002
10
0.010
 Why?
Propranolol
1
2002
50
0.010
 Why?
Phenylephrine
1
2002
75
0.010
 Why?
Mice, Mutant Strains
1
2003
298
0.010
 Why?
Adolescent
2
2018
21499
0.010
 Why?
Chemokines
1
2003
228
0.010
 Why?
Peroxidase
1
2002
176
0.010
 Why?
Mitogen-Activated Protein Kinase 3
1
2002
153
0.010
 Why?
Biological Transport
1
2003
417
0.010
 Why?
Proto-Oncogene Proteins c-bcl-2
1
2003
234
0.010
 Why?
Cyclic AMP-Dependent Protein Kinases
1
2002
135
0.010
 Why?
Young Adult
1
2018
13163
0.010
 Why?
Respiratory Burst
1
2000
16
0.010
 Why?
omega-N-Methylarginine
1
2000
27
0.010
 Why?
MAP Kinase Signaling System
1
2002
321
0.010
 Why?
Inflammation Mediators
1
2003
514
0.010
 Why?
Protein Processing, Post-Translational
1
2002
467
0.010
 Why?
Statistical Distributions
1
1999
8
0.010
 Why?
Matched-Pair Analysis
1
1999
40
0.010
 Why?
Cloning, Molecular
1
2000
536
0.010
 Why?
Intelligence Tests
1
1999
59
0.010
 Why?
Chromosomes, Human
1
1999
44
0.010
 Why?
Nuclear Family
1
1999
54
0.010
 Why?
Lipopolysaccharides
1
2003
886
0.010
 Why?
Protein-Tyrosine Kinases
1
2002
434
0.010
 Why?
Hydrogen Peroxide
1
2000
328
0.010
 Why?
Linkage Disequilibrium
1
1999
269
0.010
 Why?
Carrier Proteins
1
2003
769
0.010
 Why?
Models, Genetic
1
1999
607
0.010
 Why?
Cells, Cultured
1
2003
4197
0.010
 Why?
Cell Line
1
2000
2841
0.010
 Why?
Cytokines
1
2003
2090
0.010
 Why?
Molecular Sequence Data
1
1999
2904
0.010
 Why?
Genotype
1
1999
1923
0.010
 Why?
Sex Factors
1
1999
2073
0.010
 Why?
Macrophages
1
2000
1544
0.010
 Why?
Mice, Inbred C57BL
1
2003
5753
0.010
 Why?
Child, Preschool
1
1999
11080
0.000
 Why?
Child
1
1999
21999
0.000
 Why?
Pitts's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (400) concept(s)
_
Co-Authors Expand Description
See all (86) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)